The size of the Middle East and Africa Speciality Enzymes Market is forecasted to grow at a sluggish rate between 2021 and 2026.
The rising use of specialty enzymes in various diagnostic tests for cancer, diabetes, and heart diseases is a key driver driving the growth of the Middle East and Africa specialty enzymes market. In addition, specialty enzymes also aid in the production of low-cost medications and treatments by increasing manufacturing efficiencies. Therefore, the increasing demand for non-harmful biological catalysts in pharmaceuticals and diagnostics is expected to boost the market growth in MEA. On the other hand, the usage of specialized enzymes in fine chemicals as a biocatalyst for rapid reactions is a significant factor driving the Middle East and Africa specialty enzymes market over the forecast period.
The use of specialty enzymes increased significantly throughout the forecast period due to the increasing use of new techniques to optimize pharmaceutical production and people's concerns about quality. Moreover, the multifunctional benefits of specialty enzymes in various applications and technological developments to reduce the consumption of chemical catalysts are propelling the specialty enzyme market forward. In addition, custom enzymes have grown in popularity due to the development of tools to optimize pharmaceutical production and customer concerns about quality.
Specialty enzymes have a wide range of applications throughout the region; however, the leading players use various strategies to expand regional market growth. Furthermore, industry participants are developing advanced and innovative phytase enzymes and insisting for FDA and Center for Veterinary Medicine approval to utilize the product in animal feed diets.
The specialized enzyme market is growing due to the multifunctional benefits of specialty enzymes in various applications and technological advancements that reduce the use of chemical catalysts.
Furthermore, specialty enzymes are in great demand because of the increased use of enzymes in pharmaceutical companies. Specialty enzymes are commonly used in the pharmaceutical sector for medicine production, disease diagnosis, and therapy. The rising use of enzymes in cancer, cardiovascular disease, lysosomal storage disorders, and pain and inflammation control is one factor driving the market growth.
However, the high cost of diagnostics solutions for chronic diseases in emerging countries, and lack of awareness regarding diagnostic tests, on the other hand, are the major factors hampering the specialty enzymes market growth in the MEA region.
This research report on the MEA specialty enzymes market has been segmented and sub-segmented into the following categories:
The Middle East and Africa have an untapped market, and key players are slowly expanding to this region, which is the main reason for the market's growth in this region.
The specialty enzymes market in the Middle East and Africa had a moderate percentage of the global market in 2020. However, it is projected to record a promising share during the forecast period. Enzymes are now available for a wide range of applications due to technological improvements in the region, which is expected to boost the market's expansion. The region is expected to see the emergence of unique and superior performing items and the industrialization of the Middle East and Africa. South Africa, Saudi Arabia, UAE, and Kuwait are the leading countries expanding regional market growth.
South Africa accounted for the largest share of the market due to a significant number of biopharmaceutical companies, improving healthcare infrastructure, and favorable government regulations.
The UAE is more likely to witness a significant share in the market. The market growth is expected to be driven by new product launches with broader applications, growing awareness, improving the pharmaceutical sector, and increasing its R&D investments.
KEY MARKET PLAYERS:
A few of the noteworthy companies operating in the MEA specialty enzymes market profiled in the report are Bbi Enzymes Ltd., BASF, Codexis Inc., Nagase & Co. Ltd., Life Technologies, Advanced Enzyme Technology Ltd. Affymetrix Inc., Advanced Enzyme Technology Ltd., Amano Enzyme Inc., Roche Holding Ag., and Sanofi S.A.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.5 Y-o-Y Growth Analysis, By Source
5.1.6 Market Attractiveness Analysis, By Source
5.1.7 Market Share Analysis, By Source
188.8.131.52 Other Carbohydrases
5.2.4 Polymerases &Nucleases
5.2.7 Specialty Enzymes Used in Pharmaceuticals
5.2.8 Specialty Enzyme Used in Diagnostics
5.2.9 Specialty Enzyme Used For Research & Biotechnology
5.2.10 Y-o-Y Growth Analysis, By Type
5.2.11 Market Attractiveness Analysis, By Type
5.2.12 Market Share Analysis, By Type
184.108.40.206 Enzyme Replacement Therapy
220.127.116.11 Thrombolytic Enzymes
18.104.22.168 Digestive Enzymes
5.3.3 Research & Biotechnology
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Source
188.8.131.52 By Type
184.108.40.206 By Application
6.1.4 Market Attractiveness Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Source
22.214.171.124 By Type
126.96.36.199 By Application
6.1.5 Market Share Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Source
220.127.116.11 By Type
18.104.22.168 By Application
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Affymetrix Inc.
8.1.2 Source Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 BBI Enzymes Ltd.
8.3 Nagase & Co. Ltd.
8.4 Life Technologies
8.5 Advanced Enzyme Technology Ltd.
8.6 Roche Holding Ag
8.7 Sanofi S.A.
8.8 Codexis Inc.
8.9 Amano Enzyme Inc.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures